Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Enrolling by Invitation

Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in Adults With Irritable Bowel Syndrome Using Multimodal MRI and High-Throughput Sequencing

NCT07345377

Conditions: Colonic Diseases, Colonic Diseases, Functional, Depressive Disorder, +22 more
Locations: The affiliated hospital of Hangzhou Normal University Hangzhou, Zhejiang, China

View Trial Details

Enrolling by Invitation

Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash

NCT06665490

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Northwestern University Department of Dermatology Chicago, Illinois, United States

View Trial Details

Enrolling by Invitation

Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials

NCT07474051

Conditions: AML (Acute Myelogenous Leukemia), B-cell Lymphoma, Chronic Disease, +33 more
Locations: Charité Universitätsmedizin Berlin Berlin, Germany

Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus Dresden, Germany

Universitätsklinikum Marburg Marburg, Germany

Klinikum der Universität (LMU) Muenchen Munich, Germany

View Trial Details

Enrolling by Invitation

A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma

NCT07348575

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

View Trial Details

Enrolling by Invitation

BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line Therapy of T-cell Lymphomas

NCT07258680

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Not specified

View Trial Details

Enrolling by Invitation

Watch and Wait or Worry and Wait in Indolent Lymphoma

NCT07173790

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
Locations: Samsung Medical Center Seoul, Gangnam-gu, South Korea

Korea UniversityKorea University Guro Hospital Seoul, Guro-gu, South Korea

Seoul National University Hospital Seoul, Jongno-gu, South Korea

The Catholic University of Korea Seoul, Seocho-gu, South Korea

View Trial Details

Enrolling by Invitation

Tau PET Outcomes With Anti-amyloid Immunotherapies

NCT06723015

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +20 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Enrolling by Invitation

Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia

NCT06544798

Conditions: Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Miami Cancer Institute at Baptist Health South Florida Miami, Florida, United States

University of Iowa Iowa City, Iowa, United States

University of Missouri Columbia, Missouri, United States

View Trial Details

Enrolling by Invitation

EGPSS for Weight Management in an in Vivo Human Model

NCT07186959

Conditions: Body Weight, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
Locations: The fifth Medical Center of Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Enrolling by Invitation

CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas

NCT07168486

Conditions: B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +31 more
Locations: University of Maryland, Baltimore Baltimore, Maryland, United States

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions